Search results
US challenges ‘bogus’ patents on Ozempic and other drugs in effort to spur competition - WTOP News
WTOP Washington· 2 hours agoThe Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and< ...
Is Eli Lilly Stock A Buy After Weight-Loss Drug Crushes Quarterly Sales Forecasts?
Investor's Business Daily· 3 hours agoSales of Mounjaro and another diabetes treatment, Trulicity, lagged forecasts. ...Lilly says it's...
FTC Targets ‘Junk’ Patent Listings on Ozempic and Other Drugs
The Wall Street Journal· 4 hours agoAt issue is what is called the Orange Book, a document published by the Food and Drug Administration...
Lilly Soars as Forecast Boost Shows Weight-Loss Drugs’ Power
Bloomberg via Yahoo Finance· 2 hours ago(Bloomberg) -- Eli Lilly & Co.’s shares soared as its brighter outlook for 2024 raised the potential...
Drug appears to reverse type 1 diabetes in mice
Futurity· 3 hours agoAn experimental monoclonal antibody drug appears to prevent and reverse the onset of clinical type 1 diabetes in mice, and< ...
Some of the popular weight loss drug Wegovy is back on shelves after a shortage, the FDA says
Quartz· 23 hours agoA dose of Wegovy’s highly-coveted weight loss drug is no longer in limited supply, according to Food...
Weight-loss drug drives Eli Lilly to raise 2024 sales forecast by $2 billion
Reuters· 2 hours ago, opens new tab weight-loss drug Zepbound drove the company to raise its annual sales forecast by $2...
This Popular Weight Loss Drug May Help People With Sleep Apnea, Study Finds
Prevention· 4 days agoZepbound, a popular weight loss drug from Eli Lilly, may help people with sleep apnea. Based on...
Barbra Streisand Asks Melissa McCarthy An Abruptly Rude Question On Instagram
HuffPost via Yahoo News· 21 minutes agoCelebrities such as Amy Schumer and Sharon Osbourne have acknowledged taking the diabetes drug as an...
Why Eli Lilly's earnings are no sure thing for traders despite obesity drug momentum
CNBC· 1 day agoEli Lilly appears to be making as much of its popular obesity and diabetes medicines as it can, but...